Delivery of Wnt inhibitor WIF1 via engineered polymeric microspheres promotes nerve regeneration after sciatic nerve crush
Authors:
Open Access
- 1 January 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Tissue Engineering
- Vol. 13
Abstract
Injuries within the peripheral nervous system (PNS) lead to sensory and motor deficits, as well as neuropathic pain, which strongly impair the life quality of patients. Although most current PNS injury treatment approaches focus on using growth factors/small molecules to stimulate the regrowth of the injured nerves, these methods neglect another important factor that strongly hinders axon regeneration—the presence of axonal inhibitory molecules. Therefore, this work sought to explore the potential of pathway inhibition in promoting sciatic nerve regeneration. Additionally, the therapeutic window for using pathway inhibitors was uncovered so as to achieve the desired regeneration outcomes. Specifically, we explored the role of Wnt signaling inhibition on PNS regeneration by delivering Wnt inhibitors, sFRP2 and WIF1, after sciatic nerve transection and sciatic nerve crush injuries. Our results demonstrate that WIF1 promoted nerve regeneration ( p < 0.05) after sciatic nerve crush injury. More importantly, we revealed the therapeutic window for the treatment of Wnt inhibitors, which is 1 week post sciatic nerve crush when the non-canonical receptor tyrosine kinase (Ryk) is significantly upregulated.Keywords
Funding Information
- SingHealth-NTU Research Collaborative Grant (SHS-NTU/038/2016)
This publication has 75 references indexed in Scilit:
- The Effects of Hematopoietic Growth Factors on Neurite OutgrowthPLOS ONE, 2013
- Differential Gene Expression Profiling and Biological Process Analysis in Proximal Nerve Segments after Sciatic Nerve TransectionPLOS ONE, 2013
- Reinduced Wnt signaling limits regenerative potential of sensory axons in the spinal cord following conditioning lesionProceedings of the National Academy of Sciences, 2012
- SFRP1 and SFRP2 Dose‐Dependently Regulate Midbrain Dopamine Neuron Development In Vivo and in Embryonic Stem CellsStem Cells, 2012
- Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthaseNature Cell Biology, 2011
- Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injuryJournal of Neuroinflammation, 2011
- Wallerian degeneration: the innate-immune response to traumatic nerve injuryJournal of Neuroinflammation, 2011
- In vitro and in vivo release of nerve growth factor from biodegradable poly‐lactic‐co‐glycolic‐acid microspheresJournal of Biomedical Materials Research Part A, 2010
- Repulsive Wnt Signaling Inhibits Axon Regeneration after CNS InjuryJournal of Neuroscience, 2008
- Aligned Protein–Polymer Composite Fibers Enhance Nerve Regeneration: A Potential Tissue‐Engineering PlatformAdvanced Functional Materials, 2007